Eddy W.Y. Wong

TL;DR: The association of COVID-19 with clinical services to the public has been severely disruptive, as redistribution of manpower and resources are required to critically meet the current and anticipated hospital service needs during the outbreak.

TL;DR: Wide variation exists in tracheostomy protocols, reflecting geographical variation, different resource constraints, and limited data to drive evidence-based care standards.

TL;DR: The experience in Hong Kong on the mitigation of head and neck cancer service disruption through telehealth and multi‐institution collaboration is shared to manage the balance between infection risk to health‐care providers and the risk of disease progression from prolonged waiting times.

TL;DR: Low‐grade myofibroblastic sarcoma is a rare entity that is described as having a predilection for occurring in the head and neck region and its demographics, clinic‐pathologic, and survival characteristics are analyzed.

TL;DR: Early results of a phase 1 safety and feasibility clinical trial of the first clinical use of a novel robot for transoral robotic surgery (TORS)—the da Vinci SP clearly demonstrate that the device is safe and that it is feasible in performing TORS to access the nasopharynx, oropharynx and larynx.